Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Kyverna Therapeutics, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-24-036481 (34 Act) Size: 15943 KB |
Mar-26-2024 | 24784248 |
8-K | Document | Current report filing Acc-no: 0000950170-24-036410 (34 Act) Size: 196 KB |
Mar-26-2024 | 24783666 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-026552 (34 Act) Size: 119 KB |
Feb-22-2024 | 24665290 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-040028 (34 Act) Size: 42 KB |
Feb-20-2024 | 24653971 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-015479 ( Act) Size: 21 KB |
Feb-14-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-015473 ( Act) Size: 11 KB |
Feb-14-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-015465 ( Act) Size: 16 KB |
Feb-14-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-024091 ( Act) Size: 23 KB |
Feb-14-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-015358 ( Act) Size: 30 KB |
Feb-14-2024 | |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-036609 (34 Act) Size: 48 KB |
Feb-14-2024 | 24640661 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001062993-24-003026 ( Act) Size: 10 KB |
Feb-13-2024 | |
SEC STAFF LETTER | Document | Acc-no: 9999999997-24-000276 ( Act) Size: 62 KB | Feb-13-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-014000 ( Act) Size: 13 KB |
Feb-12-2024 | |
8-K | Document | Current report filing Acc-no: 0001193125-24-032161 (34 Act) Size: 225 KB |
Feb-12-2024 | 24620547 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-24-028421 (33 Act) Size: 327 KB |
Feb-08-2024 | 24609784 |
424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001193125-24-028334 (33 Act) Size: 6178 KB |
Feb-08-2024 | 24609002 |
CERT | Document | Acc-no: 0001354457-24-000049 (34 Act) Size: 207 KB | Feb-08-2024 | 24606948 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000950170-24-012524 ( Act) Size: 13 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000950170-24-012491 ( Act) Size: 13 KB |
Feb-08-2024 | |
EFFECT | Document | Acc-no: 9999999995-24-000343 (33 Act) Size: 1 KB | Feb-07-2024 | 24606678 |
Recent 20 filings. View all Kyverna Therapeutics, Inc. filings
Thanks I look forward to using the product to improve my skin tone
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by